Metraipolis › archive › dc_cc38fee3ef78

Efficacy and safety of Nefecon in IgA nephropathy: real world clinical practice — Europe PMC PMID:41727461

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41727461
DOI
10.3389/fimmu.2026.1761804
License (as archived)
solo-consultazione
Archived
2026-11-06T02:46:32.774Z
SHA-256 of the archived text
c022624e815a1e0a68597ef79ea232e448db57afd70ab7228958ebba484ee38c
Stable URL of this page
https://metraipolis.com/documento/dc_cc38fee3ef78

How to cite

Efficacy and safety of Nefecon in IgA nephropathy: real world clinical practice — Europe PMC PMID:41727461 — Europe PMC (en), https://europepmc.org/article/MED/41727461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc38fee3ef78 (Metraipolis archive dc_cc38fee3ef78, sha256 c022624e815a1e0a68597ef79ea232e448db57afd70ab7228958ebba484ee38c)
BibTeX
@misc{dccc38fee3ef78,
  title = {Efficacy and safety of Nefecon in IgA nephropathy: real world clinical practice — Europe PMC PMID:41727461},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41727461},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc38fee3ef78; sha256 c022624e815a1e0a68597ef79ea232e448db57afd70ab7228958ebba484ee38c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727461. Agents can read the archived copy with the MCP tool read_document.